September 28, 2018
Alnylam Head Office in Cambridge, Massachusetts Alnylam Pharmaceuticals, a US biotech leading in RNAi therapeutics, has established a Japanese subsidiary, looking to roll out four rare disease drugs in the country within five years, with the first approval expected in...read more